Recall Of Device For Critically Ill Newborns High-Risk Class I, FDA Says
The GENOSYL DS Nitric Oxide Delivery System was recalled by Vero Biotech because the device’s software could deliver an incorrect dosage of nitric oxide, a drug used on newborns experiencing respiratory failure.
You may also be interested in...
The US FDA says the 11 companies were selling masks without agency clearance, approval or authorization. A total of 13 device-related missives were released by the FDA in July.
Labelers of an array of medical devices, from contact lenses to condoms, have been given more time to comply with the US FDA’s eight-year-old Unique Device Identification rule. The agency says labelers of certain products may continue using Universal Product Codes (UPCs) on packaging through September 2023.
The US agency has announced four additional webinars aimed at labs and manufacturers that are developing – or have developed – diagnostic tests for the coronavirus.